KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Receivables - Other: 2010-2013

Historic Receivables - Other for Biomarin Pharmaceutical (BMRN) over the last 3 years, with Dec 2013 value amounting to $116.5 million.

  • Biomarin Pharmaceutical's Receivables - Other was N/A to $8.4 million in Q3 2016 from the same period last year, while for Sep 2016 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $116.5 million for FY2013, which is N/A change from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Receivables - Other stood at $116.5 million for FY2013, which was up 1,812.03% from $6.1 million recorded in FY2011.
  • Biomarin Pharmaceutical's 5-year Receivables - Other high stood at $116.5 million for FY2013, and its period low was $6.1 million during FY2011.
  • Over the past 2 years, Biomarin Pharmaceutical's median Receivables - Other value was $61.3 million (recorded in 2011), while the average stood at $61.3 million.
  • Data for Biomarin Pharmaceutical's Receivables - Other shows a maximum YoY declined of 16.63% (in 2011) over the last 5 years.
  • Yearly analysis of 3 years shows Biomarin Pharmaceutical's Receivables - Other stood at $7.3 million in 2010, then dropped by 16.63% to $6.1 million in 2011, then reached $116.5 million in 2013.